New Approach to Shrinking NF1 Tumors (IMAGE)
Caption
In a mouse model developed by experts at Cincinnati Children's, a KRAS inhibitor showed promise at reducing NF1 tumors.
Credit
Cincinnati Children's
Usage Restrictions
none
License
Original content